RxDoctor Payments Data

Alexander Vortmeyer, MD

Neuropathology · Jackson, MSNPI 1124265665

Payments from drug & device makers

$608,192in general payments, 2019–2025

Across 9 payments — averaging $67,577 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$608K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Diagnostics Corporation9$608,192

How this compares

Too few neuropathology providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$9,014
Medicare patients
42
Services billed
217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Where these figures come from

Is this you, or does something look wrong? →